Aetion Stock
Analytics Solutions for Life Sciences
Sign up today and learn more about Aetion Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Aetion Stock
Based in New York City, Aetion (pronounced eh-tee-ahn) is a leading healthcare technology company that delivers the real-world analytics and evidence needed for value-based care. With its patented rapid-cycle analytics™ technology, the Aetion Evidence Platform utilizes the everyday clinical and financial interactions of the healthcare system to unlock essential evidence about the effectiveness and value of medical treatments. Founded by Harvard Medical School faculty members and top big data technologists, Aetion enables payers and providers to collaborate with biopharmaceutical and medical device companies in real-time to develop therapeutic insights and make smart choices in patient care. The company is backed by Flare Capital Partners, Lakestar, Oxeon Ventures and other leading individual health technology investors. Learn more at www.aetion.com.
Investors
Amgen Ventures
B Capital Group
PharmEasy, Bird, Highspot, 6sense, Flutterwave, Clari, Starburst Data, Innovaccer, Newfront Insurance, Icertis
EDBI
Magic Leap, DataRobot, Nature's Fynd, Voyager Innovations, Welltok, Seismic, Inari, WuXi NextCODE, Sprinklr, Druva
Flare Capital Partners
Foresite Capital
EverlyWell, Crossover Health, Aetion, Genapsys, Mindstrong, DNAnexus
Greenspring Associates
Quibi, Scopely, Workrise, Cohesity, Tipalti, Salsify, Grove Collaborative, Stash Financial, Blockdaemon, Aviatrix
Johnson & Johnson Innovation
Lakestar
Spotify, Opendoor, Oscar Health, GetYourGuide, Blockchain.com, Symphony Communication Services, Cedar, Taulia, Aetion, Eigen Technologies
McKesson Ventures
New Enterprise Associates
Robinhood, Databricks, Jet, TAE Technologies, Scopely, Bloom Energy, Opendoor, Radiology Partners, DataRobot, Tempus
Oxeon Partners
Sanofi
UCB Pharma
Funding History
| February 2017 | $13.1M |
|---|---|
| January 2018 | $36.4M |
| December 2018 | $46.2M |
| April 2021 | $110M |
Management
Chief Executive Officer
Carolyn Magill
Chief Financial Officer
TC Fleming
Chief Technology Officer
John Turek
Press
startuparound - May, 28 2021
Aetion Raises Another $112M to Empower the Healthcare Industry with Data to Make Informed Decisions and Reduce the Time to Marketalleywatch - Sep, 2 2020
Aetion Adds Another $19M to its Series B to Make Sense of Drug Development and Treatment Datapharmiweb - Jul, 30 2020
Aetion and Cegedim Health Data announce new partnership to power real-world evidence research in Europeaetion - May, 19 2020
Aetion launches research collaboration with FDA to advance understanding of COVID-19fiercebiotech - Feb, 24 2020
Pricing watchdog ICER taps Aetion's real-world evidence platform for value assessmentsmobihealthnews - Feb, 17 2020
Glooko's newest executives, Aetion's cross-industry data expert and more digital health hiresfiercebiotech - Nov, 20 2019
Sanofi to assimilate Aetion's real-world data platform into its ownbusinesswire - Oct, 15 2019
McKesson and Aetion Collaborate to Advance Cancer Research With Real-World Datafiercehealthcare - Sep, 17 2019
Former FDA Commissioner Gottlieb joins health startup Aetion's board of directorsprnewswire - Jun, 7 2019
Horizon Healthcare Services, Inc., Partners with Aetion to Improve Treatment Pathways Using Predictive Modeling and Machine Learningmedcitynews - Feb, 6 2019
Healthcare analytics firm Aetion gets $27M from biopharma, healthcare companiesEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
